We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+24.07%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.69B
AUM Growth
+$545M
Cap. Flow
+$236M
Cap. Flow %
8.79%
Top 10 Hldgs %
25.36%
Holding
4,296
New
186
Increased
2,357
Reduced
1,127
Closed
124

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.5M
2
NVDA icon
NVIDIA
NVDA
+$12M
3
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$8.7M
4
AMZN icon
Amazon
AMZN
+$8M
5
MSFT icon
Microsoft
MSFT
+$7.83M

Top Sells

Rank Stock Value
1
MCHI icon
iShares MSCI China ETF
MCHI
+$1.41M
2
CTRA
Coterra Energy
CTRA
+$1.22M
3
HOLX
Hologic
HOLX
+$1.19M
4
HON icon
Honeywell
HON
+$1.12M
5
NFLX icon
Netflix
NFLX
+$1M

Sector Composition

Rank Sector Weight
1 Technology 29.94%
2 Financials 11.36%
3 Industrials 9.29%
4 Healthcare 8.12%
5 Consumer Discretionary 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTZ icon
3151
Hertz
HTZ
$572M
$3.46K ﹤0.01%
1,527
+845
+124% +$4.61K
ALIT icon
3152
Alight
ALIT
$497M
$3.43K ﹤0.01%
306
-155
-34% -$2.19K
TDUP icon
3153
ThredUp
TDUP
$736M
$3.42K ﹤0.01%
500
+75
+18% +$351
SMC
3154
Summit Midstream
SMC
$421M
$3.39K ﹤0.01%
119
-21
-15% -$626
PKOH icon
3155
Park-Ohio Holdings
PKOH
$554M
$3.38K ﹤0.01%
88
GERN icon
3156
Geron
GERN
$911M
$3.36K ﹤0.01%
2,626
-1,655
-39% -$2.33K
XTLB
3157
XTL Biopharmaceuticals
XTLB
$7.22M
$3.31K ﹤0.01%
1,213
-2,175
-64% -$5.6K
NRDS icon
3158
NerdWallet
NRDS
$584M
$3.29K ﹤0.01%
356
-94
-21% -$880
ASPN icon
3159
Aspen Aerogels
ASPN
$387M
$3.29K ﹤0.01%
519
ARKO icon
3160
ARKO Corp
ARKO
$890M
$3.28K ﹤0.01%
409
-60
-13% -$421
CBNA
3161
Chain Bridge Bancorp
CBNA
$277M
$3.28K ﹤0.01%
78
+5
+7% +$184
ANNX icon
3162
Annexon
ANNX
$855M
$3.25K ﹤0.01%
570
+254
+80% +$1.4K
PDYN icon
3163
Palladyne AI
PDYN
$233M
$3.24K ﹤0.01%
533
-70
-12% -$463
CBC
3164
Central Bancompany Inc
CBC
$7.68B
$3.22K ﹤0.01%
+106
New +$2.88K
TLX
3165
Telix Pharmaceuticals
TLX
$3.46B
$3.21K ﹤0.01%
+278
New +$2.83K
USAU icon
3166
US Gold Corp
USAU
$220M
$3.2K ﹤0.01%
209
-30
-13% -$475
NKSH icon
3167
National Bankshares
NKSH
$233M
$3.2K ﹤0.01%
88
PAYS icon
3168
Paysign
PAYS
$486M
$3.19K ﹤0.01%
389
+161
+71% +$1.07K
UWMC icon
3169
UWM Holdings
UWMC
$621M
$3.19K ﹤0.01%
1,391
+182
+15% +$566
CRBP icon
3170
Corbus Pharmaceuticals
CRBP
$170M
$3.15K ﹤0.01%
336
CHYM
3171
Chime Financial
CHYM
$7.88B
$3.13K ﹤0.01%
153
+132
+629% +$2.56K
JIVE icon
3172
JPMorgan International Value ETF
JIVE
$3.3B
$3.13K ﹤0.01%
34
VLGEA icon
3173
Village Super Market
VLGEA
$631M
$3.12K ﹤0.01%
74
+5
+7% +$215
FHTX icon
3174
Foghorn Therapeutics
FHTX
$285M
$3.1K ﹤0.01%
635
-229
-27% -$1.02K
ZUMZ icon
3175
Zumiez
ZUMZ
$320M
$3.08K ﹤0.01%
173

Similar funds

GAMMA Investing's Q2 2026 Portfolio in Review

As of Q2 2026, GAMMA Investing held 4,296 positions worth $2.69B, up 25% from $2.14B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

GAMMA Investing deployed $236M of net new capital in Q2 2026, opening 186 new positions and adding to 2,357 existing holdings. Its largest new stake was Honeywell Aerospace: 5,619 shares worth $1.24M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares MSCI China ETF, an estimated $1.41M trimmed.

  • GAMMA Investing's largest Q2 2026 buy was Honeywell Aerospace: 5,619 shares worth $1.24M.
  • GAMMA Investing added most to Apple in Q2 2026, an estimated $12.5M increase.
  • GAMMA Investing's biggest Q2 2026 reduction was iShares MSCI China ETF, cutting an estimated $1.41M.
  • GAMMA Investing fully exited Coterra Energy in Q2 2026, selling an estimated $1.22M.
  • GAMMA Investing's ten largest holdings make up 25% of its $2.69B portfolio in Q2 2026.
  • GAMMA Investing opened 186 new positions and closed 124 in Q2 2026.
  • GAMMA Investing's portfolio value rose 25% quarter-over-quarter to $2.69B.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.